- Dray EM, Marelli AJ. Changing epidemiology of congenital heart disease. Congenital heart disease and adolescence. Cham: Springer International Publishing; 2016. p. 3–14.
- Green A. Outcomes of congenital heart disease: a review. Pediatr Nurs. 2004;30:4.
- Donofrio MT, duPlessis AJ, Limperopoulos C. Impact of congenital heart disease on fetal brain development and injury. Curr Opin Pediatr. 2011;23(5):502–11. doi:https://doi.org/10.1097/MOP.0b013e32834aa583.
- Mussatto KA, Hoffmann R, Hoffman G, Tweddell JS, Bear L, Cao Y, Tanem J, Brosig C. Risk factors for abnormal developmental trajectories in young children with congenital heart disease. Circulation. 2015;132(8):755–61. doi:https://doi.org/10.1161/CIRCULATIONAHA.114.014521.
- Mussatto KA, Hoffmann RG, Hoffman GM, Tweddell JS, Bear L, Cao Y, Brosig C. Risk and prevalence of developmental delay in young children with congenital heart disease. Pediatrics. 2014;133(3):e570–e577. doi:https://doi.org/10.1542/peds.2013-2309.
- Billotte M, Deken V, Joriot S, Vaksmann G, Richard A, Bouzguenda I, Godart F, Baudelet J-B, Rakza T, Nguyen The Tich S. Screening for neurodevelopmental disorders in children with congenital heart disease. Eur J Pediatr. 2021;180(4):1157–67. doi:https://doi.org/10.1007/s00431-020-03850-x.
- Wernovsky G. Current insights regarding neurological and developmental abnormalities in children and young adults with complex congenital cardiac disease. Cardiol Young. 2006;16(S1):92–104. doi:https://doi.org/10.1017/S1047951105002398.
- Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, Mussatto KA, Uzark K, Goldberg CS, Johnson WH, et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126(9):1143–72. doi:https://doi.org/10.1161/CIR.0b013e318265ee8a.
- Cioni G, Inguaggiato E, Sgandurra G. Early intervention in neurodevelopmental disorders: underlying neural mechanisms. Dev Med Child Neurol. 2016;58:61–66. doi:https://doi.org/10.1111/dmcn.13050.
- Chorna O, Baldwin HS, Neumaier J, Gogliotti S, Powers D, Mouvery A, Bichell D, Maitre NL. Feasibility of a team approach to complex congenital heart defect neurodevelopmental follow-up: early experience of a combined cardiology/neonatal intensive care unit follow-up program. Circ Cardiovasc Qual Outcomes. 2016;9(4):432–40.
- Brosig C, Butcher J, Butler S, Ilardi DL, Sananes R, Sanz JH, Sood E, Struemph K, Ware J. Monitoring developmental risk and promoting success for children with congenital heart disease: recommendations for cardiac neurodevelopmental follow-up programs. Clin Pract Pediatr Psychol. 2014;2(2):153. doi:https://doi.org/10.1037/cpp0000058.
- Fourdain S, Simard M-N, Dagenais L, Materassi M, Doussau A, Goulet J, Gagnon K, Prud'Homme J, Vinay MC, Dehaes M, Birca A, Poirier NC, Carmant L, Gallagher A. Gross motor development of children with congenital heart disease receiving early systematic surveillance and individualized intervention: brief report. Dev Neurorehabil. 2020;24(1):56-62
- Loccoh EC, Yu S, Donohue J, Lowery R, Butcher J, Pasquali SK, Goldberg CS, Uzark K. Prevalence and risk factors associated with non-attendance in neurodevelopmental follow-up clinic among infants with CHD. Cardiol Young. 2018;28(4):554–60. doi:https://doi.org/10.1017/S1047951117002748.
- Monteiro SA, Serrano F, Tsang R, Smith Hollier E, Guffey D, Noll L, Voigt RG, Ghanayem N, Shekerdemian L. Ancillary referral patterns in infants after initial assessment in a cardiac developmental outcomes clinic. Congenit Heart Dis. 2019;14(5):797–802. doi:https://doi.org/10.1111/chd.12789.
- Mussatto KA, Hollenbeck-Pringle D, Trachtenberg F, Sood E, Sananes R, Pike NA, Lambert LM, Mahle WT, Goldberg DJ, Goldberg CS, et al. Utilisation of early intervention services in young children with hypoplastic left heart syndrome. Cardiol Young. 2018;28(1):126–33. doi:https://doi.org/10.1017/S104795111700169X.
- Cassidy AR, Butler SC, Briend J, Calderon J, Casey F, Crosby LE, … Butcher JL (2021). Neurodevelopmental and psychosocial interventions for individuals with CHD: a research agenda and recommendations from the Cardiac Neurodevelopmental Outcome Collaborative. Cardiology in the Young, 1–12.
- Singh A, Yeh CJ, Blanchard SB. Ages and stages questionnaire: a global screening scale. Boletín Médico Del Hospital Infantil De México (English Edition). 2017;74(1):5–12. doi:https://doi.org/10.1016/j.bmhime.2016.07.001.
- Brandlistuen RE, Stene-Larsen K, Holmstrøm H, Landolt MA, Eskedal LT, Vollrath ME. Occurrence and predictors of developmental impairments in 3-year-old children with congenital heart defects. J Dev Behav Pediatr. 2011;32(7):526–32. doi:https://doi.org/10.1097/DBP.0b013e318222eb5a.
- Schonhaut L, Armijo I, Schönstedt M, Alvarez J, Cordero M. Validity of the ages and stages questionnaires in term and preterm infants. Pediatrics. 2013;131(5):e1468–e1474. doi:https://doi.org/10.1542/peds.2012-3313.
- Skellern C, Rogers Y, O’callaghan M. A parent‐completed developmental questionnaire: follow up of ex‐premature infants. J Paediatr Child Health. 2001;37(2):125–29. doi:https://doi.org/10.1046/j.1440-1754.2001.00604.x.
- Simard M-N, Luu TM, Gosselin J. Concurrent validity of ages and stages questionnaires in preterm infants. Pediatrics. 2012;130(1):e108–e114. doi:https://doi.org/10.1542/peds.2011-3532.
- Noeder MM, Logan BA, Struemph KL, Condon N, Mueller I, Sands B, Davies RR, Sood E. Developmental screening in children with CHD: ages and stages questionnaires. Cardiol Young. 2017;27(8):1447–54. doi:https://doi.org/10.1017/S1047951117000415.
- Squires J, Bricker D. 2009. Ages & stages questionnaires, (ASQ-3). In: A parent-completed child monitoring system. Baltimore, MD, USA: Paul H. Brookes.
- Flamant C, Branger B, Tich SNT, De La Rochebrochard E, Savagner C, Berlie I, Rozé J-C. Parent-completed developmental screening in premature children: a valid tool for follow-up programs. PLoS One. 2011;6(5):5. doi:https://doi.org/10.1371/journal.pone.0020004.
- Woodward BJ, Papile L-A, Lowe JR, Laadt VL, Shaffer ML, Montman R, Watterberg KL. Use of the ages and stages questionnaire and bayley scales of infant development-II in neurodevelopmental follow-up of extremely low birth weight infants. J Perinatology. 2011;31(10):641. doi:https://doi.org/10.1038/jp.2011.1.
- Bayley N. Bayley scales of infant and toddler development: bayley-III, Vol. 7. San Antonio (TX): Harcourt Assessment, Psych. Corporation; 2006.
- Rydz D, Shevell MI, Majnemer A, Oskoui M. Topical review: developmental screening. J Child Neurol. 2005;20(1):4–21. doi:https://doi.org/10.1177/08830738050200010201.
- Tluczek A, Orland KM, Cavanagh L. Psychosocial consequences of false-positive newborn screens for cystic fibrosis. Qual Health Res. 2011;21(2):174–86. doi:https://doi.org/10.1177/1049732310382919.
- Glascoe FP. Screening for developmental and behavioral problems. Ment Retard Dev Disabil Res Rev. 2005;11(3):173–79. doi:https://doi.org/10.1002/mrdd.20068.
- Terwee CB, Bot SD, De Boer MR, van der Windt DAWM, Knol DL, Dekker J, Bouter LM, De Vet HCW. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:https://doi.org/10.1016/j.jclinepi.2006.03.012.
- Ballantyne M, Stevens B, Guttmann A, Willan A, Rosenbaum P. Maternal and infant predictors of attendance at neonatal follow‐up programmes. Child Care Health Dev. 2014;40:250–58.
- Wilcox A, Levi EE, Garrett JM. Predictors of non-attendance to the postpartum follow-up visit. Matern Child Health J. 2016;20(S1):22–27. doi:https://doi.org/10.1007/s10995-016-2184-9.
- Glascoe FP. Are overreferrals on developmental screening tests really a problem? Arch Pediatr Adolesc Med. 2001;155(1):54–59. doi:https://doi.org/10.1001/archpedi.155.1.54.
- Pinto-Martin JA, Dunkle M, Earls M, Fliedner D, Landes C. Developmental stages of developmental screening: steps to implementation of a successful program. Am J Public Health. 2005;95(11):1928–32. doi:https://doi.org/10.2105/AJPH.2004.052167.
Utility of the Ages and Stages Questionnaires 3rd Edition for Developmental Screening in Children with Surgically Repaired Congenital Heart Disease
View further author information
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.